Thermal Spray Coatings on Orthopedic Devices: When and How the FDA Reviews Your Coatings
Source abstract
Abstract
Thermal spray coatings have been commonly applied on medical devices for various reasons, e.g., surface roughening, biological fixation, and similarity of chemical composition to bone minerals. Generally, to introduce a thermal spray-coated device to the US market, a premarket review of the coated device is necessary by the US Food and Drug Administration (FDA). This article aims to improve understanding regarding FDA review of thermal spray coatings in orthopedic medical device marketing applications and expectations for information to be submitted as part of this process. While different thermal spray technologies and materials have been used for coatings on medical devices, thermal spray coatings often seen by the FDA on orthopedic devices include plasma-sprayed titanium (Ti) coatings and hydroxyapatite (HA) coatings as well as Ti/HA dual coatings. The coated devices are mostly metals (e.g., Ti alloy, cobalt-chromium alloy, stainless steel alloys) and some polymers (e.g., polyetheretherketone). The FDA does not clear or approve individual coatings or materials; rather, coatings and materials are evaluated as part of the final, finished medical device in the context of the specific device technological characteristics and intended use. The FDA has two current guidance documents for orthopedic implants with modified metallic surfaces and hydroxyapatite coatings, which outline the FDA’s recommendations for full characterization and testing of these two types of coatings, respectively. Additionally, the standards organizations (e.g., ISO and ASTM) have developed many materials and testing standards for these coatings, some of which are recognized by the FDA. It is helpful that the coating companies reference these standards for appropriate material/coating specifications, testing methods, and acceptance criteria. Depending on the intended use of the coated device, it is important that coating properties also address some items specific to that device type. Additionally, the impact of cleaning, sterilization, and packaging/shelf-life processes on the coating properties is also considered to ensure that the coated device is safe for its intended use.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Orthopaedic implants and arthroplasty · Advanced materials and composites · Bone Tissue Engineering Materials
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (23)
Show source-provided references
1. ISO 17327-1, Non-Active Surgical Implants—Implant Coating —Part 1: General Requirements, 1st edn. 2018-02.
2. FDA Website—How to Study and Market Your Device, https://www.fda.gov/medicaldevices/deviceregulationandguidance/howtomarketyourdevice/ , Page last updated: 03/27/2018. Assessed 23 Apr 2018.
3. L. Sun, C.C. Berndt, K.A. Gross, and A. Kucuk, Material Fundamentals and Clinical Performance of Plasma-Sprayed Hydroxyapatite Coatings: A Review, J. Biomed. Mater. Res., 2001, 58(5), p 570-59210.1002/jbm.1056 ↗
4. J. Muth, M. Poggie, G. Kulesha, and R.M. Meneghini, Novel Highly Porous Metal Technology in Artificial Hip and Knee Replacement: Processing Methodologies and Clinical Applications, JOM, 2013, 65(2), p 318-325. https://doi.org/10.1007/s11837-012-0528-510.1007/s11837-012-0528-5 ↗
5. A. McCabe A, M. Pickford, and J. Shawcross, The History, Technical Specifications and Efficacy of Plasma Spray Coatings Applied to Joint Replacement Prostheses. JISRF Reconstr. Rev. 6(4) 2016.10.15438/rr.6.4.136 ↗
6. W.R. Walsh, N. Bertollo, C. Christou, D. Schaffner, and R.J. Mobbs, Plasma-Sprayed Titanium Coating to Polyetheretherketone Improves the Bone-Implant Interface, Spine J., 2015, 15(5), p 1041-104910.1016/j.spinee.2014.12.018 ↗
7. C. Restrepo, T. Lettich, N. Roberts, J. Parvizi, and W.J. Hozack, Uncemented Total Hip Arthroplasty in Patients Less Than Twenty-Years, Acta Orthop. Belg., 2008, 74, p 615-622
8. A. Kienle, N. Graf, and H.J. Wilke, Does Impaction of Titanium-Coated Interbody Fusion Cages into the Disc Space Cause Wear Debris or Delamination?, Spine J., 2016, 16, p 235-24210.1016/j.spinee.2015.09.038 ↗
9. Stryker Orthopaedics Website—Accolade II Femoral Hip System Surgical Technique, https://www.stryker.com/us/en/joint-replacement/products/accolade-ii.html , Literature Number: LSP76 Rev.3. Accessed 22 August 2018.
10. DePuy Synthes Institute, LLC Website—Corail® Hip System Surgical Technique, https://www.depuysynthesinstitute.com/hip/qs/10612-82-501 . Last updated: 07/20/2018. Accessed 22 August 2018.
11. Aurora Spine USA Website—Product line, https://www.aurora-spine.com/product-line-v02/ . Accessed 5 July 2018.
12. FDA Website—Regulatory Controls, https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/Overview/GeneralandSpecialControls/ucm2005378.htm , Page last updated: 03/27/2018. Accessed 5 July 2018.
13. J.R. Foy and B.D. Buch, Orthopaedic Joint Devices: The FDA’s Short Answers to Your Questions, J. Am. Acad. Orthop. Surg., 2008, 16(Supplement 1), p S123-S12810.5435/00124635-200800001-00024 ↗
14. FDA Website—Master Files, http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/HowtoMarketYourDevice/PremarketSubmissions/PremarketApprovalPMA/ucm142714.htm , Page last updated: 11/14/2017. Accessed 5 July 2018.
15. FDA Website—PMA Application Contents, https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/HowtoMarketYourDevice/PremarketSubmissions/PremarketApprovalPMA/ucm050289.htm#req , Page last updated: 6/13/2018. Accessed 5 July 2018.
16. FDA Website—Guidance Document for Testing Orthopedic Implants with Modified Metallic Surfaces Apposing Bone or Bone Cement (1994), http://www.fda.gov/downloads/MedicalDevices/…/ucm081247.pdf . Accessed 5 July 2018.
17. FDA Website—510(k) Information Needed for Hydroxyapatite Coated Orthopedic Implants, dated March 10, 1995 (revised February 20, 1997), https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/ucm080224.htm , Page last updated: 03/22/2018. Accessed 5 July 2018.
18. FDA Website—Guidance Documents (Medical Devices and Radiation-Emitting Products), http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/ , Page last updated: 03/27/2018. Assessed 31 May 2018.
19. FDA Website—Recognized Consensus Standards, http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfStandards/search.cfm , Page last updated: 06/11/2018. Assessed 31 May 2018.
20. NIST Website—National Institute of Standards & Technology (NIST) Standard Reference Material (SRM) 2910B, https://www-s.nist.gov/srmors/view_detail.cfm?srm=2910B , Page last updated: 05/30/2018. Assessed 17 August 2018.
21. FDA Website—Use of International Standard ISO 10993-1, Biological Evaluation of Medical Devices—Part 1: Evaluation and Testing Within a Risk Management Process, https://www.fda.gov/downloads/medicaldevices/deviceregulationandguidance/guidancedocuments/ucm348890.pdf , Assessed 31 May 2018.
22. FDA Website—510(k) Submission Process, https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/HowtoMarketYourDevice/PremarketSubmissions/PremarketNotification510k/ucm070201.htm , Page last updated: 02/06/2018. Assessed 31 May 2018.
23. FDA Website—PMA Review Process, https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/HowtoMarketYourDevice/PremarketSubmissions/PremarketApprovalPMA/ucm047991.htm , Page last updated: 02/22/2018. Assessed 31 May 2018.